Related Experiment Video
Updated: Jun 11, 2026
05:01
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
Pathway analysis comparison using Crohn's disease genome wide association studies
David Ballard1, Clara Abraham, Judy Cho
1Robert S Boas Center for Human Genetics and Genomics, Feinstein Institute for Medical Research, Manhasset, New York, USA. dballard@nshs.edu
BMC Medical Genomics
|June 30, 2010
Summary
The Random Set method effectively identifies disease-related pathways in Crohn's disease research. Controlling for significant genes provides deeper biological insights into complex conditions.
Area of Science:
- Genomics
- Bioinformatics
- Systems Biology
Background:
- Biological annotation, including genes and pathways, aids gene expression data analysis and genome-wide association studies (GWAS).
- Previous GWAS have identified disease-related pathways, but optimal methods for gene-level scoring and pathway interpretation remain unclear.
Purpose of the Study:
- To evaluate pathway-based methods for identifying disease-associated pathways in Crohn's disease.
- To determine the effectiveness of gene-level scoring and controlling for significant genes in GWAS.
Main Methods:
- Applied two pathway-based methods: Random Set and Binomial approximation to the hypergeometric test.
- Utilized three Crohn's disease datasets, analyzing both disease status and residuals after conditioning on IL23R.
Main Results:
- The Random Set method demonstrated the highest power in identifying disease-related pathways.
- Confirmed known Crohn's disease pathways and identified IL-2 Receptor Beta Chain in T cell Activation and IL-9 signaling as novel associated pathways.
Conclusions:
- Powerful gene scoring methods are crucial before pathway enrichment tests.
- Controlling for genome-wide significant genes enhances biological understanding in GWAS.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...